Perrigo Company plc
PRGONYSEHealthcare● Active
$11.61
+$0.78(+7.20%)
Market Cap$1.6B
P/E Ratio—
52W High$28.44
52W Low$9.23
Perrigo Company plc（PRGO）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · PRGO · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($1.40B) | ($0.17B) | ($0.01B) | ($0.13B) | ($0.07B) |
| Depreciation & Amort. | $0.34B | $0.33B | $0.36B | $0.34B | $0.31B |
| Stock-Based Comp. | $0.00B | $0.06B | $0.07B | $0.00B | $0.06B |
| Change in Working Capital | ($0.10B) | ($0.07B) | ($0.06B) | $0.02B | ($0.30B) |
| Net Cash from Operations | $0.24B | $0.36B | $0.41B | $0.31B | $0.16B |
| Investing Activities | |||||
| Capital Expenditure | ($0.09B) | ($0.12B) | ($0.10B) | ($0.10B) | ($0.15B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.08B) | $0.08B | ($0.08B) | ($1.96B) | $1.28B |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | ($0.16B) | ($0.15B) | ($0.15B) | ($0.14B) | ($0.13B) |
| Debt Issued / Repaid | ($0.03B) | ($0.44B) | ($0.03B) | $0.58B | ($0.03B) |
| Net Cash from Financing | ($0.22B) | ($0.61B) | ($0.19B) | $0.42B | ($0.18B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.15B | $0.24B | $0.30B | $0.21B | $0.00B |
| FCF Margin %(computed) | 3.41% | 5.59% | 6.53% | 4.74% | 0.10% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Perrigo Company plc
关于Perrigo Company plc（PRGO）现金流量表
Perrigo Company plc 2025财年经营活动现金流$0.24B，自由现金流$0.15B（FCF利润率3.41%），资本支出($0.09B)。
常见问题
PRGO · 4 问Perrigo Company plc 2025财年自由现金流$0.15B，同比down40.7%。
PRGO free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10